cell & molecular biology, immunology, funding, clinical trials
Nobel-Winning Biochemist Paul Boyer Dies
Nobel-Winning Biochemist Paul Boyer Dies
Shawna Williams | Jun 7, 2018
The UCLA researcher was lauded for figuring out how ATP synthase works.
Image of the Day: New Kids on the Block
Image of the Day: New Kids on the Block
Sukanya Charuchandra | Jun 7, 2018
Researchers discover that a layer of human breast tissue is not one but two distinct cell types.  
Medical Statistician Doug Altman Dies
Medical Statistician Doug Altman Dies
Kerry Grens | Jun 5, 2018
The cofounder of the EQUATOR Network devoted his career to boosting transparency and improving the quality of clinical research.
New Insights to Improve CAR T Cells’ Safety
New Insights to Improve CAR T Cells’ Safety
Vicki Brower | Jun 5, 2018
Drugs approved to treat rheumatoid arthritis block cytokines, the molecules responsible for severe side effects from the immunotherapy, and reduce symptoms in mice.
Companies to Help People Sell or Rent Out Their Health Data
Companies to Help People Sell or Rent Out Their Health Data
Catherine Offord | Jun 5, 2018
Luna DNA, Nebula Genomics, and other “bio-brokers” will allow customers to make money by granting access to their genetic and personal information for research purposes.
A T-Cell Tweak Combats Advanced Breast Cancer
A T-Cell Tweak Combats Advanced Breast Cancer
Ashley Yeager | Jun 5, 2018
The immunotherapy eliminated a woman’s metastatic lesions and kept her disease-free for two years.
Immunotherapy Drug Shows Promise for Melanoma, Lung Cancer
Immunotherapy Drug Shows Promise for Melanoma, Lung Cancer
Sukanya Charuchandra | Jun 4, 2018
Merck’s Keytruda extended the lives of lung cancer patients by several months and appeared to stop the progression of advanced melanoma.  
Study Finds No Race or Gender Bias in Grant Peer Review
Study Finds No Race or Gender Bias in Grant Peer Review
Shawna Williams | Jun 1, 2018
The paper’s authors say bias may nevertheless be present in other steps of the granting process.
Cell Transplant Trial for Spinal Injury Is Safe
Cell Transplant Trial for Spinal Injury Is Safe
Ruth Williams | Jun 1, 2018
The first human experiment with neural precursor cells implanted to treat chronic spinal cord injury suggests the procedure is safe, and hints at a small benefit.  
Youssef Belkhadir Deciphers Plants’ Signaling Soundtrack
Youssef Belkhadir Deciphers Plants’ Signaling Soundtrack
Ashley Yeager | Jun 1, 2018
An entrepreneurial attitude helped this Vienna-based researcher begin to unravel the complex receptor network that Arabidopsis uses to develop and defend itself.